Liquid Biopsy Market - Global Industry Analysis

Liquid Biopsy Market by Target Analyte (Circulating Tumor Cells (Ctcs), Circulating Tumor DNA (CtDNA), Exosomes, Nucleosomes, and Other Biomarkers), by Analytical (Molecular, Proteomic, and Histology/Imaging), by Application (Routine Screening, Patient Work-Up, Early-Stage Disease, and Late-Stage/Metastatic Disease), by Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Brain Cancer, and Others), by Sample (Blood, Urine, and Others), and by End-User (Hospitals, Research Laboratories, Academia, and Research Centers): Global Industry Perspective Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 09-May-2019 Category: Pharmaceutical Report Format : PDF Pages: 130 Report Code: ZMR-884 Status : Published

Global liquid biopsy market expected to generate approximately USD 12,062 million by 2025, at a CAGR of slightly above 38.3% between 2019 and 2025. A biopsy is a tissue or cell sample taken from any part of the human body, which is sent to the lab for examining various disease types.

Request Free Brochure of Liquid Biopsy Market

Your personal details are safe and secured with us. Privacy Policy SSL site seal - click to verify

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social